Trademark: 86793794
Status Date
Friday, March 10, 2023
Registration Number
5030314
Registration Date
Tuesday, August 30, 2016
Filing Date
Tuesday, October 20, 2015
Published for Opposition
Tuesday, June 14, 2016
Cancellation Date
Friday, March 10, 2023
5 Buccal tablets for medical use for use in the treatment of anxiety, PTSD, panic disorders, pain, seizures, insomnia, Crohn's disease, irritable bowel syndrome, ulcerative colitis, and multiple sclerosis and other neurodegenerative diseases, and medical treatment side-effects, namely, those associated with chemotherapy and radiation treatment for cancer; Drug delivery agents in the form of a troche that facilitate the delivery of pharmaceutical preparations; Medicated lozenges
Mar 10, 2023
Cancelled Sec. 8 (6-Yr)
Aug 30, 2021
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Aug 29, 2019
Withdrawal Of Attorney Granted
Aug 29, 2019
Teas Withdrawal Of Attorney Received
Oct 10, 2018
Automatic Update Of Assignment Of Ownership
Aug 30, 2016
Registered-Principal Register
Jun 14, 2016
Official Gazette Publication Confirmation E-Mailed
Jun 14, 2016
Published For Opposition
May 25, 2016
Notification Of Notice Of Publication E-Mailed
May 11, 2016
Law Office Publication Review Completed
May 4, 2016
Approved For Pub - Principal Register
May 4, 2016
Teas/Email Correspondence Entered
May 4, 2016
Correspondence Received In Law Office
Apr 28, 2016
Assigned To Lie
Apr 15, 2016
Teas Response To Office Action Received
Feb 10, 2016
Notification Of Non-Final Action E-Mailed
Feb 10, 2016
Non-Final Action E-Mailed
Feb 10, 2016
Non-Final Action Written
Feb 10, 2016
Assigned To Examiner
Oct 28, 2015
New Application Office Supplied Data Entered
Oct 23, 2015
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
